Galapagos NV
GLPG
#4563
Rank
$2.11 B
Marketcap
$31.59
Share price
-0.57%
Change (1 day)
17.04%
Change (1 year)

EPS for Galapagos NV (GLPG)

EPS in 2025 (TTM): -$0.34

According to Galapagos NV's latest financial reports the company's current EPS (TTM) is -$0.34. In 2024 the company made an earnings per share (EPS) of $1.17 a decrease over its 2023 EPS that were of $3.55.

EPS history for Galapagos NV from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-$0.34-129.1%
2024$1.17-67.16%
2023$3.55-199.64%
2022-$3.5699.03%
2021-$1.79-68.98%
2020-$5.77-298.06%
2019$2.91-554.64%
2018-$0.64-77.18%
2017-$2.81-326.21%
2016$1.24-134.19%
2015-$3.63-371.34%
2014$1.34-445.98%
2013-$0.3932.88%
2012-$0.29-82.07%
2011-$1.62-817.9%
2010$0.2312.73%
2009$0.20-120.79%
2008-$0.96-37.67%
2007-$1.5539.64%
2006-$1.1128.17%
2005-$0.866.25%
2004-$0.81

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
AstraZeneca
AZN
$3.04-994.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
$10.44-3,178.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
$3.71-1,192.75%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
$1.35-498.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
-$1.47 333.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
$8.06-2,475.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
$0.63-285.78%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
$3.60-1,160.38%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
$7.59-2,339.29%๐Ÿ‡บ๐Ÿ‡ธ USA